PLS-DA regression model from untargeted metabolomics of serum samples from children infected with dengue and controls.

PLS-DA regression model from untargeted metabolomics of serum samples from children infected with dengue and controls.

<p><b>A.</b> PLS-DA 2D Score plot exhibiting a tendence of separation between groups. <b>B.</b> Cross-validation of PLS-DA shows a Q2 of 0.7 for the regression model. <b>C.</b> VIP scores show a metabolite panel with 15 <i>m/z</i> with differenti...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Ricardo E. Correa Fierro (22676430) (author)
مؤلفون آخرون:	Noroska Gabriela Mogollón Salazar (22676433) (author), Washington B. Cárdenas (3213597) (author), Evencio Joel Medina-Villamizar (22676436) (author), Jefferson Pastuña-Fasso (22676439) (author), Melanie Ochoa-Ocampo (21222826) (author), Giovanna Morán-Marcillo (22676442) (author), Mary Ernestina Regato Arrata (22676445) (author), Mildred Zambrano (16641645) (author), Joyce Andrade (16641648) (author), Juan Chang (8280894) (author), Saurabh Mehta (367781) (author), Fernanda Bertuccez Cordeiro (16641642) (author)
منشور في:	2025
الموضوعات:	Biochemistry Medicine Microbiology Cell Biology Biotechnology Cancer Virology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified receiver operating characteristic highest predictive power faster patient screening component 5 showing complex immune response serum lipid metabolome evaluate biomarker performance denv ), triggers serum lipidomics profiling new diagnostic tools div >< p disproportionately affects children assess group separation pediatric dengue fever dengue virus infection denv infected group dengue virus dengue fever lipid metabolism diagnostic methods diagnosis tools dengue research biomarker potential biomarker discovery z </ subtropical regions metabolic alterations may contribute mass spectrometry key role glycerol lipids fatty acids despite advancements curve analysis adolescents infected 68345 ). 15 ).
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.
حسب: Ricardo E. Correa Fierro (22676430)
منشور في: (2025)

Workflow of untargeted metabolomics in serum samples from children infected with DENV.
حسب: Ricardo E. Correa Fierro (22676430)
منشور في: (2025)

ROC curve analysis of a set of biomarkers obtained via untargeted metabolomics in serum samples from children infected with DENV compared to Control.
حسب: Ricardo E. Correa Fierro (22676430)
منشور في: (2025)

Univariate ROC curves for individual analysis of the 15 <i>m/z</i> suggested as biomarkers.
حسب: Ricardo E. Correa Fierro (22676430)
منشور في: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
حسب: Sarita Paudel (15047430)
منشور في: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
حسب: Sarita Paudel (15047430)
منشور في: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
حسب: Sarita Paudel (15047430)
منشور في: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
حسب: Sarita Paudel (15047430)
منشور في: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
حسب: Sarita Paudel (15047430)
منشور في: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
حسب: Sarita Paudel (15047430)
منشور في: (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
حسب: James R. Larkin (14936324)
منشور في: (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
حسب: James R. Larkin (14936324)
منشور في: (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
حسب: James R. Larkin (14936324)
منشور في: (2025)

Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
حسب: James R. Larkin (14936324)
منشور في: (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
حسب: James R. Larkin (14936324)
منشور في: (2025)

Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
حسب: James R. Larkin (14936324)
منشور في: (2025)

Orthogonal partial least squares-discriminant analysis (OPLS-DA) of serum metabolomics data.
حسب: Ji-Xin Zhao (22056386)
منشور في: (2025)

A Four-Gene Signature from Blood to Exclude Bacterial Etiology of Lower Respiratory Tract Infection in Adults
حسب: Edward E. Walsh (20760337)
منشور في: (2025)

Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
حسب: Jun Wang (15051911)
منشور في: (2025)

Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Supplementary Table S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
حسب: Javier Pascual (15018176)
منشور في: (2025)

Relationship between estimated probability of a dengue virus infection (DENV) found during model testing for Model 9 (incorporating paired IgG, IgM, GM HAI, and acute GM HAI serological data) and the number of serological assays (RT-PCR, HAI, and EIA) that interpret the individual as having an infection.
حسب: Marco Hamins-Puértolas (15238661)
منشور في: (2025)

Table 1_Cross-species validation of a 6-miRNA blood signature for Parkinson’s disease: from MPTP mice to human PBMC and serum exosomes.docx
حسب: Nagyum Jung (22686458)
منشور في: (2025)

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
حسب: Nicola S. Meagher (15048462)
منشور في: (2025)

Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial:aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
حسب: Maria C. Jugan (18928389)
منشور في: (2025)

Association between Exposures of Interest with Serum Lipopolysaccharide and Troponin Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
حسب: Maria C. Jugan (18928389)
منشور في: (2025)

Association between Exposures of Interest with Serum Cytokine Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
حسب: Maria C. Jugan (18928389)
منشور في: (2025)

Descriptive Statistics of Serum Concentrations of Cytokines, Lipopolysaccharides and Cardiac Troponin by Severity Stage in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
حسب: Maria C. Jugan (18928389)
منشور في: (2025)

Acute and convalescent data for serological assays, colored by probability of infection found during model testing for Model 9. a) Geometric mean titers of a haemagglutination inhibition assay (GM HAI) for all four serotypes of dengue virus. b) Immunoglobulin G (IgG) c) Immunoglobulin M (IgM) d) Ratio of IgM to IgG at both acute and convalescent sera samples.
حسب: Marco Hamins-Puértolas (15238661)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_dftdg6k5rj3gouuvsnrcukjua6